In 2025, Hikma Pharmaceuticals disclosed key data related to its energy management practices, providing transparency into its operational energy use in line with recognized sustainability reporting frameworks.
Hikma Pharmaceuticals disclosed progress toward renewable energy adoption, highlighting the share of total energy sourced from renewable versus non-renewable sources.
| Metric (GJ) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Energy Consumption | 1,693,058a | 1,517,702a | 1,553,155a | |
Non-Renewable Energy Consumption | 1,527,196a | 1,359,846a | 1,424,185a | |
Renewable Energy Consumption | 165,863a | 157,856a | 128,970a | |
Renewable Energy Production | 33,509a | 30,053a | 11,858a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, Hikma Pharmaceuticals consumed a total of 1.69 million Gigajoules of energy across its operations. Of this total, 9.8% was sourced from renewable energy, either derived from natural resources like biofuels, biomass, or biogas, or generated using renewable technologies such as solar or wind power. The remaining 90.2% was classified as non-renewable energy, coming from fossil-based fuels such as coal, natural gas, or crude oil, or from non-renewable generation technologies like nuclear power.a
In 2025, Hikma Pharmaceuticals consumed a total of 1.69 million Gigajoules of energy, of which 9.8% was derived from renewable sources, including biofuels, biomass, biogas, solar, and wind power.a
This low level of renewable energy use highlights a heavy reliance on fossil fuels or other non-renewable sources, suggesting that Hikma Pharmaceuticals has considerable room to improve its energy sustainability strategy.
Since 2020, Hikma Pharmaceuticals's total energy consumption increased by 1.35%, including a 11.55% increase in 2025, reflecting a sustained rise in overall energy demand.a
Over the same period, the share of renewable energy increased by 6,199.8%, but declined by 5.81% in 2025, suggesting recent volatility or sourcing constraints.a
Overall, Hikma Pharmaceuticals’s energy trends reveal a complex picture, with variations in total consumption and renewable sourcing. A closer examination of operational drivers and sourcing strategies is needed to fully assess the company’s environmental impact.